Mechanisms and Consequences of Phagocyte Adhesion to Endothelium

References

• Bone R C, Balk R A, Cerra F B, Dellinger R P, Fein A M, Knaus W A, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644–55
   PubMed Web of Science ®Google Scholar
• Bevilacqua M P, Nelson R M, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med 1994; 45: 361–78
   PubMed Web of Science ®Google Scholar
• Kubes P, Suzuki M, Granger D N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651–5
   PubMed Web of Science ®Google Scholar
• Sata M, Walsh K. TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat Med 1998; 4: 415–20
   PubMed Web of Science ®Google Scholar
• Preece G, Murphy G, Ager A. Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J Biol Chem 1996; 271: 11634–40
   PubMed Web of Science ®Google Scholar
• Yarema K J, Bertozzi C R. Chemical approaches to glycobiology and emerging carbohydrate-based therapeutic agents. Curr Opin Chem Biol 1998; 2: 49–61
   PubMed Web of Science ®Google Scholar
• Lefer A M. Selectins: vital vasculotropic vectors involved in vascular remodeling. Circulation 1997; 96: 3258–60
   Google Scholar
• Frenette P S, Wagner D D. Insights into selectin function from knockout mice. Throtnb Haemost 1997; 78: 60–4
   Google Scholar
• Varki A. Selectin ligands: will the real ones please stand up?. J Clin Invest 1997; 99: 158–62
   PubMed Web of Science ®Google Scholar
• Diamond M S, Springer T A. The dynamic regulation of integrin adhesiveness. Curr Biol 1994; 4: 506–17
   PubMed Web of Science ®Google Scholar
• Gahmberg C G, Tolvanen M, Kotovuori P. Leukocyte adhesion. Structure and function of human beta2-integrins and their cellular ligands. Eur J Biochem 1997; 245: 215–32
   PubMedGoogle Scholar
• Hughes P E, Pfaff M. Integrin affinity modulation. Cell Biol 1998; 8: 359–64
   Google Scholar
• Bazzoni G, Hemler M E. Are changes in integrin affinity and conformation overemphasized?. Trends Biochem Sci 1998; 23: 30–4
   PubMed Web of Science ®Google Scholar
• Xie J, Li R, Kotovuori P, Vermot-Desroch C, Wijdenes J, Arnaout M A, et al. Intercellular adhesion molecule-2 (CD 102) binds to the leukocyte integrin CD lib/CD 18 through the A domain. ] Immunol 1995; 155: 3619–28
   PubMed Web of Science ®Google Scholar
• Issekutz A C, Rowter D, Springer T A. Role of ICAM-1 and ICAM-2 and alternate CD11/CD18 ligand in neutrophil transendothelial migration. J Leukoc Biol 1999; 65: 117–26
   PubMed Web of Science ®Google Scholar
• Repo H, Rochon Y P, Schwartz B R, Sharar S R, Winn R K, Harlan J M. Binding of human peripheral blood polymorphonuclear leukocytes to E-selectin (CD62E) does not promote their activation. J Immunol 1997; 159: 943–51
   PubMed Web of Science ®Google Scholar
• Newman P J. The biology of PECAM-1. J Clin Invest 1997; 99: 3–7
   PubMed Web of Science ®Google Scholar
• Duncan G S, Andrew D P, Takimoto H, Kaufman S A, Yoshida H, Spellberg J, et al. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 1999; 162: 3022–30
   PubMed Web of Science ®Google Scholar
• Ware J A, Heistad D D. Platelet-endothelium interactions. N Engl J Med 1993; 328: 628–35
   PubMed Web of Science ®Google Scholar
• Kuijper P H, Gallardo Torres HI, van der Linden J A, Lammers J W, Sixma J J, Koenderman L, et al. Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions. Blood 1996; 87: 3271–81
   PubMed Web of Science ®Google Scholar
• Kuijper P H, Gallardo Torres HI, Lammers J-WJ, Sixma J J, Koenderman L, Zwaginga J J. Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions. Blood 1997; 89: 166–75
   PubMed Web of Science ®Google Scholar
• Weber C, Springer T A. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphallbbeta3 and stimulated by platelet-activating factor. J Clin Invest 1997; 100: 2085–93
   PubMed Web of Science ®Google Scholar
• Kirchhofer D, Riederer M A, Baumgartner H R. Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model. Blood 1997; 89: 1270–8
   PubMed Web of Science ®Google Scholar
• Ostrovsky L, King A J, Bond S, Mitchell D, Lorant D E, Zimmerman G A, et al. A juxtacrine mechanism for neutrophil adhesion on platelets involves platelet-activating factor and a selectin-dependent activation process. Blood 1998; 91: 3028–36
   PubMed Web of Science ®Google Scholar
• Palabrica T, Lobb R, Furie B C, Aronovitz M, Benjamin C, Hsu Y M, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359: 848–51
   PubMed Web of Science ®Google Scholar
• Abrams C, Shattil S J. Immunological detection of activated platelets in clinical disorders. Thromb Haemost 1991; 65: 467–73
   PubMed Web of Science ®Google Scholar
• Czervionke R L, Hoak J C, Fry G L. Effect of aspirin on thrombin-induced adherence of platelets to cultured cells from the blood vessel wall. J Clin Invest 1978; 62: 847–56
   PubMedGoogle Scholar
• Fry G L, Czervionke R L, Hoak J C, Smith J B, Haycraft D L. Platelet adherence to cultured vascular cells: influence of prostacyclin (PGI2). Blood 1980; 55: 271–5
   PubMedGoogle Scholar
• Kaplan J E, Moon D G, Weston L K, Minnear F L, Del Vecchio P J, Shepard J M, et al. Platelets adhere to thrombin-treated endothelial cells in vitro. Am J Physiol 1989; 257: H423–33
   PubMed Web of Science ®Google Scholar
• Tloti M A, Moon D G, Weston L K, Kaplan J E. Effect of 13-hydroxy-octadeca-9,11-dienoic acid (13-HODE) on thrombin induced platelet adherence to endothelial cells in vitro. Thromb Res 1991; 62: 305–17
   PubMed Web of Science ®Google Scholar
• Diacovo T G, Puri K D, Warnock R A, Springer T A, von Andrian U H. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 1996; 273: 252–5
   PubMed Web of Science ®Google Scholar
• Li J M, Podolsky R S, Rohrer M J, Cutler B S, Massie M T, Barnard M R, et al. Adhesion of activated platelets to venous endothelial ceils is mediated via GPIIb/IIIa. J Surg Res 1996; 61: 543–8
   Google Scholar
• Manduteanu I, Calb M, Lupu C, Simionescu N, Simionescu M. Increased adhesion of human diabetic platelets to cultured valvular endothelial cells. J Submicrosc Cytol Pathol 1992; 24: 539–47
   PubMed Web of Science ®Google Scholar
• Frenette P S, Johnson R C, Hynes R O, Wagner D D. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995; 92: 7450–4
   PubMed Web of Science ®Google Scholar
• Massberg S, Enders G, Leiderer R, Eisenmenger S, Vestweber D, Krombach F, et al. Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 1998; 92: 507–15
   PubMed Web of Science ®Google Scholar
• Etingin O R, Silverstein R L, Hajjar D P. Von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. Proc Natl Acad Sci USA 1993; 90: 5153–6
   PubMedGoogle Scholar
• Buchanan M R, Bertomeu M C, Haas T A, Orr F W, Eltringham-Smith L L. Localization of 13-hydroxyoctadeca-dienoic acid and the vitronectin receptor in human endothelial cells and endothelial cell/platelet interactions in vitro. Blood 1993; 81: 3303–12
   PubMed Web of Science ®Google Scholar
• Bertomeu M C, Gallo S, Lauri D, Levine M N, Orr F W, Buchanan M R. Chemotherapy enhances endothelial cell reactivity to platelets. Clin Exp Metastasis 1990; 8: 511–8
   Web of Science ®Google Scholar
• Rosenblum W I, Nelson G H, Wormley B, Werner P, Wang J, Shih C CY. Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo. Stroke 1996; 27: 709–11
   PubMed Web of Science ®Google Scholar
• Bombeli T, Schwartz B R, Harlan J M. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbllla-dependent bridging mechanism and novel roles for intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIb alpha. J Exp Med 1998; 187: 329–39
   PubMed Web of Science ®Google Scholar
• Hawrylowicz C M, Howells G L, Feldmann M. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med 1991; 174: 785–90
   PubMed Web of Science ®Google Scholar
• Kaplanski G, Porat R, Aiura K, Erban J K, Gelfand J A, Dinarello C A. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 1993; 81: 2492–5
   PubMedGoogle Scholar
• Henn V, Slupsky J R, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591–4
   PubMed Web of Science ®Google Scholar
• Hynes R O, Wagner D D. Genetic manipulation of vascular adhesion molecules in mice. J Clin Invest 1996; 98: 2193–5
   PubMed Web of Science ®Google Scholar
• Hayward A R, Harvey B A, Leonard J, Greenwood M C, Wood C B, Soothill J F. Delayed separation of the umbilical cord, wide-spread infections, and defective neutrophil mobility. Lancet 1979; 1: 1099–101
   PubMed Web of Science ®Google Scholar
• Lipnick R N, Iliopoulos A, Salata K, Hershey J, Melnick D, Tsokos G C. Leukocyte adhesion deficiency: report of a case and review of the literature. Clin Exp Rheumatol 1996; 14: 95–8
   Google Scholar
• Anderson D C. Leucocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med 1987; 38: 175–94
   PubMed Web of Science ®Google Scholar
• Arnaout M A. Leucocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol Rev 1990; 114: 145–80
   PubMed Web of Science ®Google Scholar
• Le Deist F, Blanche S, Keable H, Gaud C, Pham H, Descamp-Latscha B, et al. Successful HLA non-identical bone marrow transplantation in three patients with the leukocyte adhesion deficiency. Blood 1989; 74: 512–6
   PubMed Web of Science ®Google Scholar
• Bauer T R, Schwartz B R, Conrad Liles W, Ochs H D, Hickstein D D. Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1. Blood 1998; 91: 1520–6
   Google Scholar
• Kuijpers T W, van Lier R A, Hamann D, de Boer M, Thung L Y, Weening R S, et al. Leukocyte adhesion deficiency type 1 (LAD-1)/Variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest 1997; 100: 1725–33
   PubMed Web of Science ®Google Scholar
• Hogg N, Stewart M P, Scarth S L, Newton R, Shaw J M, Law S K, et al. A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J Clin Invest 1999; 103: 97–106
   PubMed Web of Science ®Google Scholar
• Etzioni A, Frydman M, Pollack S, Avidor I, Phillips M L, Paulson J C, et al. Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 1992; 327: 1789–92
   PubMed Web of Science ®Google Scholar
• von Andrian U H, Berger E M, Ramezani L, Chambers J D, Ochs H D, Harlan J M, et al. In vivo behavior of neutrophils from two patints with distinct inherited leukocyte adhesion deficiency syndromes. J Clin Invest 1993; 91: 2893–7
   PubMed Web of Science ®Google Scholar
• Phillips L M, Schwartz B R, Etzioni A, Bayer R, Ochs H D, Paulson J C, et al. Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2. J Clin Invest 1995; 93: 2898–906
   Google Scholar
• Cornejo C J, Winn R K, Harlan J M. Anti-adhesion therapy. Adv Pharmacol 1997; 39: 99–142
   PubMedGoogle Scholar
• Menger M D, Vollmar B. Adhesion molecules as determinants of disease: from molecular biology to surgical research. Br J Surg 1996; 83: 588–601
   PubMed Web of Science ®Google Scholar
• Barnes P J, Karin M. Nuclear factor-kappaB; a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066–71
   PubMed Web of Science ®Google Scholar
• Madan M, Berkowitz S D, Tcheng J E. Glycoprotein Iib/IIIa integrin blockade. Circulation 1998; 98: 2629–35
   PubMed Web of Science ®Google Scholar
• Topol E J, Byzova T V, Plow E F. Platelet GPIIb-IIIa blockers. Lancet 1999; 353: 227–31
   PubMed Web of Science ®Google Scholar
• Sligh J E, Jr., Ballantyne C M, Rich S S, Hawkins H K, Smith C V, Bradley A, et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1993; 90: 8529–33
   PubMed Web of Science ®Google Scholar
• Xu H, Gonzalo J A, St Pierre Y, Williams I R, Kupper T S, Cotran R S, et al. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med 1994; 180: 95–109
   PubMed Web of Science ®Google Scholar
• Argenbright L W, Letts L G, Rothlein R. Monoclonal antibodies to the leukocyte membrane CD 18 glycoprotein complex and to intercellular adhesion molecule-1 inhibit leukocyte-endothelial adhesion in rabbits. J Leukoc Biol 1991; 49: 253–7
   PubMed Web of Science ®Google Scholar
• Bowes M P, Rothlein R, Fagan S C, Zivin J A. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 1995; 45: 815–9
   PubMed Web of Science ®Google Scholar
• Haug C E, Colvin R B, Delmonico F L, Auchincloss H, Jr., Tolkoff-Rubin N, Preffer F I, et al. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993; 55: 766–72
   PubMed Web of Science ®Google Scholar
• Kavanaugh A F, Davis L S, Nichols L A, Norris S H, Rothlein R, Scharschmidt L A, et al. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 1994; 37: 992–9
   PubMed Web of Science ®Google Scholar
• Vuorte J, Lindsberg P, Kaste M, Meri S, Jansson S E, Rothlein R, et al. Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol 1999; 162: 2353–7
   PubMed Web of Science ®Google Scholar
• Arnaout M A, Hakim R M, Todd R F, 3rd, Dana N, Cohen H R. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med 1985; 312: 457–62
   PubMed Web of Science ®Google Scholar
• Scherman D G. The Enlimomab Acute Stroke Trial: final results (abstract). Neurology 1997; 48: A270
   Google Scholar
• Bennett C F, Condon T, Grimm S, Chan H, Chiang M Y. Inhibition of endothelial cell-leukocyte adhesion molecule expression with antisense oligonucleotides. J Immunol 1994; 152: 3530–40
   PubMed Web of Science ®Google Scholar
• Yacyshyn B R, Bowen-Yacyshyn M B, Jewell L, Tami J A, Bennett C F, Kisner D L, et al. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. Gastroenterology 1998; 114: 1133–42
   PubMed Web of Science ®Google Scholar
• Vedder N B, Winn R K, Rice C L, Chi E Y, Arfors K E, Harlan J M. Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear. Proc Natl Acad Sci USA 1990; 87: 2643–6
   PubMed Web of Science ®Google Scholar
• Ma X L, Tsao P S, Lefer A M. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest 1991; 88: 1237–43
   PubMed Web of Science ®Google Scholar
• Winn R K, Ramamoorthy C, Vedder N B, Sharar S R, Harlan J M. Leukocyte-endothelial cell interactions in ischemia-reperfusion injury. Ann N Y Acad Sci 1997; 832: 311–21
   PubMed Web of Science ®Google Scholar
• Botha A J, Moore F A, Moore E E, Sauaia A, Banerjee A, Peterson V M. Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma 1995; 39: 411–7
   PubMed Web of Science ®Google Scholar
• Sharar S R, Winn R K, Murry C E, Harlan J M, Rice C L. A CD18 monoclonal antibody increases the incidence and severity of subcutaneous abscess formation after high-dose Staphylococcus aureus injection in rabbits. Surgery 1991; 110: 213–9
   PubMed Web of Science ®Google Scholar
• Vedder N, Harlan J, Winn R, Heckbert S, Maier R, Hudson L, et al. Pilot phase 2 clinical trial of a humanized CD11/CD18 monoclonal antibody in hemorrhagic shock (abstract). Shock 1997; 7: A659
   Google Scholar
• Bone R C. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996; 24: 163–72
   PubMed Web of Science ®Google Scholar
• Salvo I, de Cian W, Musicco M, Langer M, Piadena R, Wolfler A, et al. The Italian SEPSIS study: preliminary results on the incidence and evoultion of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 1995; 21: S244–9
   PubMed Web of Science ®Google Scholar
• Heckbert S R, Vedder N B, Hoffman W, Hudson L D, Jurkowich G J, Copass M K, et al. Outcome after hemorrhagic shock in trauma patients. J Trauma 1998; 45: 545–9
   PubMed Web of Science ®Google Scholar
• Calafat J, Kuijpers T W, Janssen H, Borregaard N, Verhoeven J A, Roos D. Evidence for small intracellular vesicles in human blood phagocytes containing cytochrome b558 and the adhesion molecule CDllb/CD18. Blood 1993; 81: 3122–9
   PubMed Web of Science ®Google Scholar
• Rinder C S, Bonan J L, Rinder H M, Mathew J, Hinds R, Smith B R. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79: 1201–5
   PubMed Web of Science ®Google Scholar
• Repo H, Jansson S E, Leirisalo-Repo M. Flow cytometric determination of CD11b upregulation in vivo. J Immunol Methods 1993; 164: 193–202
   PubMed Web of Science ®Google Scholar
• Lin R Y, Astiz M E, Saxon J C, Rackow E C. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest 1993; 104: 847–53
   PubMed Web of Science ®Google Scholar
• Lin R Y, Astiz M E, Saxon J C, Saha D C, Rackow E D. Relationship between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med 1994; 22: 1595–1602
   Google Scholar
• Nelson R D, Hasslen S R, Ahrenholz D H, Haus E, Solem L D. Influence of minor thermal injury on expression of complement receptor CR3 on human neutrophils. Am J Pathol 1986; 125: 563–70
   Google Scholar
• Takala A J, Jousela I T, Takkunen O S, Jansson S E, Kyosola K T, Olkkola K T, et al. Time course of beta2-integrin CD11b/CD 18 (Mac-1, alpha Mbeta 2) upregulation on neutrophils and monocytes after coronary artery bypass grafting. Scand J Thorac Cardiovasc Surg 1996; 30: 141–8
   PubMed Web of Science ®Google Scholar
• Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996; 61: 1714–20
   PubMed Web of Science ®Google Scholar
• Takala A, Jousela I, Olkkola K T, Jansson S E, Leirisalo-Repo M, Takkunen O, et al. Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients admitted to hospital in a medical emergency. Clin Sci 1999; 96: 287–95
   Google Scholar
• Rosenbloom A J, Pinsky M R, Bryant J L, Shin A, Tran T, Whiteside T. Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction. JAMA 1995; 274: 58–65
   PubMed Web of Science ®Google Scholar
• Thiel M, Imendörffer S, Chouker A, Groh J, Briegel J, Anthuber M, et al. Expression of adhesion molecules on circulating polymorphonuclear leukocytes during orthotopic liver transplantation. Hepatology 1998; 28: 1538–50
   PubMedGoogle Scholar
• Inoue T, Sakai Y, Mooraka S, Hayashi T, Takayanagi K, Takabatake Y. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996; 28: 1127–33
   PubMed Web of Science ®Google Scholar
• Mickelson J K, Lakkis N M, Villarreal-Levy G, Hughes B J, Smith C W. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?. J Am Coll Cardiol 1996; 28: 345–53
   PubMed Web of Science ®Google Scholar
• Damas P, Canivet J L, de Groote D, Vrindts Y, Albert Y, Franchimont P, et al. Sepsis and serum cytokine concentrations. Crit Care Med 1997; 25: 405–12
   PubMed Web of Science ®Google Scholar
• Grau G E, Maennel D N. TNF inhibition and sepsis -sounding a cautionary note. Nat Med 1997; 3: 1193–5
   Google Scholar
• Lefering R, Neugebauer E A. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995; 23: 1294–303
   PubMed Web of Science ®Google Scholar
• Cronin L, Cook D J, Carlet J, Heyland D K, King D, Lansang M A, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995; 23: 1430–9
   PubMed Web of Science ®Google Scholar
• Meduri G U, Headley A S, Golden E, Carson S J, Umberger R A, Kelso T, et al. Effect of prolonged methylprednisolone therapy on unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998; 280: 159–65
   PubMed Web of Science ®Google Scholar
• Döcke W D, Randow F, Syrbe U, Carson S J, Umberger R A, Kelso T, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997; 3: 678–81
   PubMed Web of Science ®Google Scholar